Interviews

Empowering Vulnerable Populations: The Path to Equitable Biologic Therapy Access

December 22nd 2024

Article

Elie Bahou, PharmD, senior vice president and system chief pharmacy officer at Providence, discusses strategies to improve equitable access to biologic therapies, including tiered formularies, income-based cost sharing, patient assistance programs, and fostering payer partnerships.

Strategies for Improving Biosimilar Access and Utilization

December 15th 2024

Video

Elie Bahou, PharmD, senior vice president and system chief pharmacy officer at Providence, discussed barriers to biosimilar adoption and highlighted strategies such as physician education, streamlined implementation, payer collaboration, and patient engagement to improve access, reduce costs, and enhance adherence to biologic therapies.

AI-Powered Solutions for Streamlining Biosimilar Prescribing and Monitoring

December 8th 2024

Video

Steve Pickette, PharmD, BCPS, emphasizes that AI can streamline prescribing and formulary management for biosimilars and generics, enhance provider engagement, and improve pharmacovigilance by tracking adoption rates and identifying potential issues.

How Early Adopters Are Shaping the Future of Biosimilars

November 24th 2024

Article

Early adopters of biosimilars have paved the way for broader acceptance by sharing real-world success strategies, overcoming initial resistance, and highlighting best practices for integration and cost savings.

Can Global Policies to Boost Biosimilar Adoption Work in the US?

November 17th 2024

Article

On this special episode of Not So Different honoring Global Biosimilars Week, Craig Burton, executive director of the Biosimilars Council, explores how global policies—from incentives to health equity strategies—could boost biosimilar adoption in the US.

How Strategic IDNs Boost Biosimilar Adoption

November 10th 2024

Video

Sophia Humphreys, PharmD, MHA, BCBBS, director of system formulary management at Sutter Health, discusses how integrated delivery networks (IDNs) can help drive biosimilar adoption.

Addressing Hesitance in Biosimilar Adoption

October 20th 2024

Video

Sophia Humphreys, PharmD, from Sutter Health explains that expanding biosimilars into new therapeutic areas faces hesitance due to maintenance therapies, emphasizing the importance of education.

From Skepticism to Success: Insights Into Biosimilar Market Acceptance

October 13th 2024

Video

Ivo Abraham, PhD, RN, director of the Center for Health Outcomes and PharmacoEconomic Research at the University of Arizona Cancer Center, discusses the potential of biosimilars and challenges in the US, emphasizing partnerships for market growth.

Future Biosimilar Trends, Challenges, and Opportunities

September 29th 2024

Video

Ivo Abraham, PhD, RN, University of Arizona Cancer Center, explains how biosimilars are becoming more accessible but face challenges like price erosion and potential shortages.

The Role of Risk-Sharing Models in Biosimilar Adoption

September 22nd 2024

Video

Ivo Abraham, PhD, RN, University of Arizona Cancer Center, analyzes the need for innovative risk-sharing models to promote biosimilar development and utilization.